Fig. 2

The HBV-DNA level at baseline and at HBVr occurrence. The significant increase in HBV-DNA levels was identified in all three cohorts at HBVr occurrence compared to baseline levels. No statistical difference of HBV-DNA level was observed between the Group B and Group C at HBVr occurrence and 3-month follow-up. Group A, the entire cohort; Group B, the patients with immunotherapy; Group C, the patients without immunotherapy. * P <.05; ** P <.001. HBV, hepatitis B virus; HBVr, hepatitis B virus reactivation